InVivo Therapeutics (OTC: NVIV) announced an interim successor to fill the Chief Science Officer position recently vacated by Dr. Edward Wirth due to personal reasons. Brian
Tracking down the DNA contained in fabric is not just for a modern-day Sherlock Holmes trying to solve a murder mystery. Applied DNA Sciences (OTC:
Animals may not have the dexterity to manipulate a keyboard or the mental ability to choose what is best for them, but social media and
Traders were anything but sedate today when it came to buying shares of Titan Pharmaceuticals (OTC: TTNP). About two hours after the opening of the
As any actor knows, the key to a strong performance begins with an impressionable entrance onto the scene. The stock of Seven Arts Entertainment (OTC:
MAM Software (OTC: MAMS) released its fourth quarter and year-end financial results an hour after the opening bell this morning. For the quarter, the automotive
How hot or cold can a stock get from a research report created by a non-registered, small cap equity research firm? Traders probably pondered that
Is the Corona Discharge Electrostatic Motor enough to jolt the interest of traders into shares of SEFE (OTC: SEFE)? The company announced today that it had
InspireMD (OTC: NSPR) released its fiscal year 2012 financials this morning. Due to the transition of a different month for the fiscal year end, financial
Beginning on September 12, 2012, shares of Lifevantage (OTC: LFVN) will commence trading on the NASDAQ under the same symbol that the stock carries now.
Nanoviricides (OTC: NNVC) reported today that its oral anti-influenza drug, FluCide, showed superior results to oral Tamiflu. Produced by Roche, Tamiflu has become the standard treatment
From the news over the last week, Cellceutix (OTC: CTIX) looks as if it will be making hospital rounds in the near future with its
Gold exploration companies love finding a rich vein of the shiny metal and an economy that prints lots of money. Central bankers in Europe and
Augme Technologies (OTC: AUGT) whispered its earnings preview today for the second quarter of FY 2013 that ended on August 31, 2012. The company expects revenues for
Traders in IZEA (OTC:IZEA) had to dodge several sharp utensils falling from the sky this summer. First, the Facebook (NASDAQ: FB) initial public offering debacle
InVivo Therapeutics (OTC: NVIV) announced an interim successor to fill the Chief Science Officer position recently vacated by Dr. Edward Wirth due to personal reasons. Brian
Tracking down the DNA contained in fabric is not just for a modern-day Sherlock Holmes trying to solve a murder mystery. Applied DNA Sciences (OTC:
Animals may not have the dexterity to manipulate a keyboard or the mental ability to choose what is best for them, but social media and
Traders were anything but sedate today when it came to buying shares of Titan Pharmaceuticals (OTC: TTNP). About two hours after the opening of the
As any actor knows, the key to a strong performance begins with an impressionable entrance onto the scene. The stock of Seven Arts Entertainment (OTC:
MAM Software (OTC: MAMS) released its fourth quarter and year-end financial results an hour after the opening bell this morning. For the quarter, the automotive
How hot or cold can a stock get from a research report created by a non-registered, small cap equity research firm? Traders probably pondered that
Is the Corona Discharge Electrostatic Motor enough to jolt the interest of traders into shares of SEFE (OTC: SEFE)? The company announced today that it had
InspireMD (OTC: NSPR) released its fiscal year 2012 financials this morning. Due to the transition of a different month for the fiscal year end, financial
Beginning on September 12, 2012, shares of Lifevantage (OTC: LFVN) will commence trading on the NASDAQ under the same symbol that the stock carries now.
Nanoviricides (OTC: NNVC) reported today that its oral anti-influenza drug, FluCide, showed superior results to oral Tamiflu. Produced by Roche, Tamiflu has become the standard treatment
From the news over the last week, Cellceutix (OTC: CTIX) looks as if it will be making hospital rounds in the near future with its
Gold exploration companies love finding a rich vein of the shiny metal and an economy that prints lots of money. Central bankers in Europe and
Augme Technologies (OTC: AUGT) whispered its earnings preview today for the second quarter of FY 2013 that ended on August 31, 2012. The company expects revenues for
Traders in IZEA (OTC:IZEA) had to dodge several sharp utensils falling from the sky this summer. First, the Facebook (NASDAQ: FB) initial public offering debacle
